Site US00004 Roswell Park Cancer Institute — Buffalo, New York

Site US00004 Roswell Park Cancer Institute is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Site US00004 Roswell Park Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology, Renal Cell Carcinoma With Clear Cell Histology.

Sponsors: Agensys, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US00004 Roswell Park Cancer Institute?

Site US00004 Roswell Park Cancer Institute has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US00004 Roswell Park Cancer Institute conducted?

Site US00004 Roswell Park Cancer Institute has 1 clinical trials on record. Their work covers Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology, Renal Cell Carcinoma With Clear Cell Histology.

Is Site US00004 Roswell Park Cancer Institute accredited by Crixeo Health?

Site US00004 Roswell Park Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US00004 Roswell Park Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.